INFUSION OF ETOPOSIDE AND VINCRISTINE IN NON-HODGKINS LYMPHOMA

被引：59

作者：

JACKSON, DV

POWELL, BL

CRUZ, JM

SPURR, CL

MUSS, HB

机构：

来源：

SELECTIVE CANCER THERAPEUTICS | 1989年 / 5卷 / 03期

关键词：

D O I：

10.1089/sct.1989.5.129

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：129 / 136

页数：8

共 34 条

[1] A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE) [J].

AISNER, J ;

VANECHO, DA ;

WHITACRE, M ;

WIERNIK, PH .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :157-160

[2]

AISNER J, 1983, P AM SOC CLIN ONCOL, V2, P194

[3] ACTIVITY OF THE EPIPODOPHYLLOTOXIN VP-16 IN THE TREATMENT OF COMBINATION CHEMOTHERAPY-RESISTANT NON-HODGKIN LYMPHOMA [J].

BENDER, RA ;

ANDERSON, T ;

FISHER, RI ;

YOUNG, RC .

AMERICAN JOURNAL OF HEMATOLOGY, 1978, 5 (03) :203-209

[4]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715

[5]

FLIER JS, 1987, NEW ENGL J MED, V316, P1388

[6]

HANSEN MM, 1980, CANCER TREAT REP, V64, P1135

[7]

JACKSON D, 1988, P AM ASSOC CANC RES, V29, P217

[8]

JACKSON DV, 1987, ISI ATLAS-PHARMACOL, V1, P124

[9] LACK OF POTENTIATION OF VINCRISTINE-INDUCED NEUROTOXICITY BY VP-16-213 [J].

JACKSON, DV ;

WELLS, HB ;

WHITE, DR ;

MUSS, HB ;

RICHARDS, F ;

COOPER, MR ;

STUART, JJ ;

POPE, EK ;

SPURR, CL .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03) :327-330

[10] VINBLASTINE INFUSION IN NON-HODGKINS LYMPHOMAS - LACK OF TOTAL CROSS-RESISTANCE WITH VINCRISTINE [J].

JACKSON, DV ;

SPURR, CL ;

CAPONERA, ME ;

WHITE, DR ;

MUSS, HB ;

PAVY, MD ;

SARTIANO, GP ;

ZEKAN, PJ ;

HIRE, EA .

CANCER INVESTIGATION, 1987, 5 (06) :535-539

← 1 2 3 4 →